nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—THBD—stomach cancer	0.0117	0.522	CrCbGaD
Baclofen—Ibuprofen—CXCL8—stomach cancer	0.00368	0.165	CrCbGaD
Baclofen—Ibuprofen—PPARG—stomach cancer	0.00254	0.114	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—stomach cancer	0.0024	0.108	CrCbGaD
Baclofen—GABBR1—GPCR ligand binding—KISS1R—stomach cancer	0.00175	0.0138	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—KISS1—stomach cancer	0.00175	0.0138	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—SLC1A2—stomach cancer	0.00162	0.0128	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—KISS1R—stomach cancer	0.00153	0.0121	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HSPA8—stomach cancer	0.00151	0.0118	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.00143	0.0112	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KISS1R—stomach cancer	0.00139	0.011	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—HSPA8—stomach cancer	0.00127	0.00996	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HRH4—stomach cancer	0.00127	0.00996	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—AGTR2—stomach cancer	0.00121	0.00955	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—HTR1A—stomach cancer	0.00117	0.0092	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—AGTR2—stomach cancer	0.00114	0.00898	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—ANXA1—stomach cancer	0.00113	0.00888	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—KISS1—stomach cancer	0.00113	0.00888	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—F2R—stomach cancer	0.00113	0.00888	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—HRH4—stomach cancer	0.00111	0.00873	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—HTR1A—stomach cancer	0.0011	0.00864	CbGpPWpGaD
Baclofen—Ibuprofen—PTGS2—stomach cancer	0.00107	0.0481	CrCbGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.00107	0.00843	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ANXA1—stomach cancer	0.00106	0.00835	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ADRB1—stomach cancer	0.00103	0.00808	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HRH4—stomach cancer	0.00101	0.00793	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—KISS1R—stomach cancer	0.000989	0.00778	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—KISS1—stomach cancer	0.000989	0.00778	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HSPA8—stomach cancer	0.00097	0.00764	CbGpPWpGaD
Baclofen—Ibuprofen—ALB—stomach cancer	0.000956	0.0429	CrCbGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000921	0.00725	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCB—stomach cancer	0.000918	0.00723	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KISS1R—stomach cancer	0.000898	0.00707	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KISS1—stomach cancer	0.000898	0.00707	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—GAST—stomach cancer	0.00085	0.00669	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—RGS2—stomach cancer	0.00085	0.00669	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ADRB2—stomach cancer	0.000832	0.00655	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GLI3—stomach cancer	0.000823	0.00648	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KISS1R—stomach cancer	0.000823	0.00648	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—PRKCB—stomach cancer	0.000821	0.00646	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000789	0.00621	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RBP1—stomach cancer	0.000785	0.00618	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—GAST—stomach cancer	0.000772	0.00608	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—RGS2—stomach cancer	0.000772	0.00608	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—AGTR2—stomach cancer	0.000735	0.00579	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000734	0.00578	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—F2R—stomach cancer	0.000727	0.00572	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HRH4—stomach cancer	0.000715	0.00563	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR1A—stomach cancer	0.000707	0.00557	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—PRKCB—stomach cancer	0.00069	0.00544	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—ANXA1—stomach cancer	0.000683	0.00538	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—stomach cancer	0.000664	0.00522	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—ADRB1—stomach cancer	0.000662	0.00521	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRH4—stomach cancer	0.000649	0.00511	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AGTR2—stomach cancer	0.000644	0.00507	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—WWOX—stomach cancer	0.00064	0.00504	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—KISS1—stomach cancer	0.000637	0.00502	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—F2R—stomach cancer	0.000637	0.00502	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—HTR1A—stomach cancer	0.00062	0.00488	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—ANXA1—stomach cancer	0.000599	0.00472	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRH4—stomach cancer	0.000595	0.00469	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—WIF1—stomach cancer	0.000595	0.00469	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.000589	0.00464	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AGTR2—stomach cancer	0.000585	0.00461	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—ADRB1—stomach cancer	0.00058	0.00457	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KISS1—stomach cancer	0.000579	0.00456	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—F2R—stomach cancer	0.000579	0.00456	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HTR1A—stomach cancer	0.000563	0.00443	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000552	0.00434	CbGpPWpGaD
Baclofen—Angiopathy—Methotrexate—stomach cancer	0.000552	0.000648	CcSEcCtD
Baclofen—Vomiting—Irinotecan—stomach cancer	0.000551	0.000648	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PRKAB1—stomach cancer	0.000549	0.00432	CbGpPWpGaD
Baclofen—Dizziness—Fluorouracil—stomach cancer	0.000549	0.000645	CcSEcCtD
Baclofen—Visual impairment—Epirubicin—stomach cancer	0.000548	0.000645	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—RGS2—stomach cancer	0.000548	0.00431	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—GAST—stomach cancer	0.000548	0.00431	CbGpPWpGaD
Baclofen—Mediastinal disorder—Methotrexate—stomach cancer	0.000548	0.000644	CcSEcCtD
Baclofen—Rash—Irinotecan—stomach cancer	0.000547	0.000643	CcSEcCtD
Baclofen—Dermatitis—Irinotecan—stomach cancer	0.000546	0.000642	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000546	0.000642	CcSEcCtD
Baclofen—Chills—Methotrexate—stomach cancer	0.000545	0.000641	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ANXA1—stomach cancer	0.000544	0.00428	CbGpPWpGaD
Baclofen—Headache—Irinotecan—stomach cancer	0.000543	0.000638	CcSEcCtD
Baclofen—Hypotension—Capecitabine—stomach cancer	0.000542	0.000637	CcSEcCtD
Baclofen—Insomnia—Docetaxel—stomach cancer	0.000542	0.000637	CcSEcCtD
Baclofen—Paraesthesia—Docetaxel—stomach cancer	0.000538	0.000633	CcSEcCtD
Baclofen—Alopecia—Methotrexate—stomach cancer	0.000537	0.000632	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ADRB2—stomach cancer	0.000536	0.00422	CbGpPWpGaD
Baclofen—Bradycardia—Doxorubicin—stomach cancer	0.000536	0.00063	CcSEcCtD
Baclofen—Dyspnoea—Docetaxel—stomach cancer	0.000534	0.000628	CcSEcCtD
Baclofen—Somnolence—Docetaxel—stomach cancer	0.000533	0.000626	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—stomach cancer	0.000533	0.000626	CcSEcCtD
Baclofen—Eye disorder—Epirubicin—stomach cancer	0.000532	0.000625	CcSEcCtD
Baclofen—Tinnitus—Epirubicin—stomach cancer	0.00053	0.000624	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RNF43—stomach cancer	0.00053	0.00418	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KISS1—stomach cancer	0.00053	0.00418	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GLI3—stomach cancer	0.00053	0.00418	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KISS1R—stomach cancer	0.00053	0.00418	CbGpPWpGaD
Baclofen—Malnutrition—Methotrexate—stomach cancer	0.000529	0.000622	CcSEcCtD
Baclofen—GABBR1—Neuronal System—PRKCB—stomach cancer	0.000529	0.00416	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000529	0.000621	CcSEcCtD
Baclofen—Flushing—Epirubicin—stomach cancer	0.000528	0.000621	CcSEcCtD
Baclofen—Cardiac disorder—Epirubicin—stomach cancer	0.000528	0.000621	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—stomach cancer	0.000528	0.000621	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—stomach cancer	0.000528	0.00062	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—stomach cancer	0.000528	0.00062	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADRB1—stomach cancer	0.000527	0.00415	CbGpPWpGaD
Baclofen—Insomnia—Capecitabine—stomach cancer	0.000525	0.000617	CcSEcCtD
Baclofen—Hypoaesthesia—Doxorubicin—stomach cancer	0.000524	0.000616	CcSEcCtD
Baclofen—Rash—Fluorouracil—stomach cancer	0.000524	0.000615	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—stomach cancer	0.000523	0.000615	CcSEcCtD
Baclofen—Paraesthesia—Capecitabine—stomach cancer	0.000521	0.000612	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—stomach cancer	0.000521	0.000612	CcSEcCtD
Baclofen—Headache—Fluorouracil—stomach cancer	0.00052	0.000611	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—stomach cancer	0.00052	0.000611	CcSEcCtD
Baclofen—Oedema peripheral—Doxorubicin—stomach cancer	0.000519	0.00061	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—stomach cancer	0.000518	0.000609	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000517	0.000608	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—stomach cancer	0.000517	0.000608	CcSEcCtD
Baclofen—Dyspnoea—Capecitabine—stomach cancer	0.000517	0.000608	CcSEcCtD
Baclofen—Fatigue—Docetaxel—stomach cancer	0.000517	0.000607	CcSEcCtD
Baclofen—Angiopathy—Epirubicin—stomach cancer	0.000516	0.000607	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—stomach cancer	0.000516	0.000607	CcSEcCtD
Baclofen—Nausea—Irinotecan—stomach cancer	0.000515	0.000605	CcSEcCtD
Baclofen—Mediastinal disorder—Epirubicin—stomach cancer	0.000513	0.000603	CcSEcCtD
Baclofen—Pain—Docetaxel—stomach cancer	0.000512	0.000602	CcSEcCtD
Baclofen—Constipation—Docetaxel—stomach cancer	0.000512	0.000602	CcSEcCtD
Baclofen—Back pain—Methotrexate—stomach cancer	0.000512	0.000602	CcSEcCtD
Baclofen—Dyspepsia—Capecitabine—stomach cancer	0.000511	0.0006	CcSEcCtD
Baclofen—Chills—Epirubicin—stomach cancer	0.00051	0.0006	CcSEcCtD
Baclofen—Arrhythmia—Epirubicin—stomach cancer	0.000508	0.000597	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—stomach cancer	0.000507	0.000596	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RBP1—stomach cancer	0.000506	0.00398	CbGpPWpGaD
Baclofen—Decreased appetite—Capecitabine—stomach cancer	0.000504	0.000593	CcSEcCtD
Baclofen—Alopecia—Epirubicin—stomach cancer	0.000503	0.000591	CcSEcCtD
Baclofen—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000501	0.000589	CcSEcCtD
Baclofen—Fatigue—Capecitabine—stomach cancer	0.0005	0.000588	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—stomach cancer	0.000499	0.000586	CcSEcCtD
Baclofen—Mental disorder—Epirubicin—stomach cancer	0.000498	0.000586	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—RGS2—stomach cancer	0.000498	0.00392	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GAST—stomach cancer	0.000498	0.00392	CbGpPWpGaD
Baclofen—Constipation—Capecitabine—stomach cancer	0.000496	0.000583	CcSEcCtD
Baclofen—Pain—Capecitabine—stomach cancer	0.000496	0.000583	CcSEcCtD
Baclofen—Malnutrition—Epirubicin—stomach cancer	0.000495	0.000582	CcSEcCtD
Baclofen—Feeling abnormal—Docetaxel—stomach cancer	0.000494	0.000581	CcSEcCtD
Baclofen—Nausea—Fluorouracil—stomach cancer	0.000493	0.00058	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—stomach cancer	0.000492	0.000578	CcSEcCtD
Baclofen—Ill-defined disorder—Methotrexate—stomach cancer	0.000491	0.000577	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—stomach cancer	0.000491	0.000577	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—stomach cancer	0.00049	0.000576	CcSEcCtD
Baclofen—Anaemia—Methotrexate—stomach cancer	0.000489	0.000575	CcSEcCtD
Baclofen—Flushing—Doxorubicin—stomach cancer	0.000489	0.000574	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—stomach cancer	0.000489	0.000574	CcSEcCtD
Baclofen—Flatulence—Epirubicin—stomach cancer	0.000488	0.000574	CcSEcCtD
Baclofen—Dysgeusia—Epirubicin—stomach cancer	0.000485	0.00057	CcSEcCtD
Baclofen—Back pain—Epirubicin—stomach cancer	0.000479	0.000563	CcSEcCtD
Baclofen—Feeling abnormal—Capecitabine—stomach cancer	0.000478	0.000562	CcSEcCtD
Baclofen—Angiopathy—Doxorubicin—stomach cancer	0.000478	0.000561	CcSEcCtD
Baclofen—Malaise—Methotrexate—stomach cancer	0.000477	0.000561	CcSEcCtD
Baclofen—Vertigo—Methotrexate—stomach cancer	0.000475	0.000559	CcSEcCtD
Baclofen—Gastrointestinal pain—Capecitabine—stomach cancer	0.000474	0.000558	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—stomach cancer	0.000474	0.000558	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—stomach cancer	0.000474	0.000557	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—stomach cancer	0.000474	0.000557	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—stomach cancer	0.000473	0.00372	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FST—stomach cancer	0.000473	0.00372	CbGpPWpGaD
Baclofen—Chills—Doxorubicin—stomach cancer	0.000472	0.000555	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—stomach cancer	0.00047	0.000553	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ADRB2—stomach cancer	0.00047	0.0037	CbGpPWpGaD
Baclofen—Vision blurred—Epirubicin—stomach cancer	0.000467	0.000549	CcSEcCtD
Baclofen—Alopecia—Doxorubicin—stomach cancer	0.000465	0.000547	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—HBEGF—stomach cancer	0.000463	0.00364	CbGpPWpGaD
Baclofen—Mental disorder—Doxorubicin—stomach cancer	0.000461	0.000542	CcSEcCtD
Baclofen—Urticaria—Capecitabine—stomach cancer	0.000461	0.000542	CcSEcCtD
Baclofen—Ill-defined disorder—Epirubicin—stomach cancer	0.00046	0.00054	CcSEcCtD
Baclofen—Abdominal pain—Capecitabine—stomach cancer	0.000459	0.000539	CcSEcCtD
Baclofen—Body temperature increased—Capecitabine—stomach cancer	0.000459	0.000539	CcSEcCtD
Baclofen—Convulsion—Methotrexate—stomach cancer	0.000459	0.000539	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—stomach cancer	0.000458	0.000539	CcSEcCtD
Baclofen—Anaemia—Epirubicin—stomach cancer	0.000458	0.000538	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RGS2—stomach cancer	0.000456	0.00359	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GAST—stomach cancer	0.000456	0.00359	CbGpPWpGaD
Baclofen—Agitation—Epirubicin—stomach cancer	0.000455	0.000535	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—stomach cancer	0.000452	0.000531	CcSEcCtD
Baclofen—Chest pain—Methotrexate—stomach cancer	0.000451	0.00053	CcSEcCtD
Baclofen—Myalgia—Methotrexate—stomach cancer	0.000451	0.00053	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—stomach cancer	0.000449	0.000528	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000447	0.000526	CcSEcCtD
Baclofen—Malaise—Epirubicin—stomach cancer	0.000447	0.000525	CcSEcCtD
Baclofen—Discomfort—Methotrexate—stomach cancer	0.000445	0.000523	CcSEcCtD
Baclofen—Vertigo—Epirubicin—stomach cancer	0.000445	0.000523	CcSEcCtD
Baclofen—Syncope—Epirubicin—stomach cancer	0.000444	0.000522	CcSEcCtD
Baclofen—Back pain—Doxorubicin—stomach cancer	0.000443	0.000521	CcSEcCtD
Baclofen—GABBR2—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000443	0.00349	CbGpPWpGaD
Baclofen—Palpitations—Epirubicin—stomach cancer	0.000438	0.000515	CcSEcCtD
Baclofen—Confusional state—Methotrexate—stomach cancer	0.000436	0.000512	CcSEcCtD
Baclofen—Loss of consciousness—Epirubicin—stomach cancer	0.000435	0.000512	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGG—stomach cancer	0.000432	0.0034	CbGpPWpGaD
Baclofen—Vision blurred—Doxorubicin—stomach cancer	0.000432	0.000508	CcSEcCtD
Baclofen—Asthenia—Docetaxel—stomach cancer	0.00043	0.000505	CcSEcCtD
Baclofen—Convulsion—Epirubicin—stomach cancer	0.000429	0.000504	CcSEcCtD
Baclofen—Infection—Methotrexate—stomach cancer	0.000429	0.000504	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—stomach cancer	0.000428	0.00337	CbGpPWpGaD
Baclofen—Hypertension—Epirubicin—stomach cancer	0.000428	0.000503	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADRB2—stomach cancer	0.000427	0.00336	CbGpPWpGaD
Baclofen—Ill-defined disorder—Doxorubicin—stomach cancer	0.000425	0.0005	CcSEcCtD
Baclofen—Pruritus—Docetaxel—stomach cancer	0.000424	0.000498	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—stomach cancer	0.000424	0.000498	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—stomach cancer	0.000424	0.000498	CcSEcCtD
Baclofen—GABBR2—Neuronal System—MAPK1—stomach cancer	0.000423	0.00333	CbGpPWpGaD
Baclofen—Chest pain—Epirubicin—stomach cancer	0.000422	0.000496	CcSEcCtD
Baclofen—Myalgia—Epirubicin—stomach cancer	0.000422	0.000496	CcSEcCtD
Baclofen—Agitation—Doxorubicin—stomach cancer	0.000421	0.000495	CcSEcCtD
Baclofen—Anxiety—Epirubicin—stomach cancer	0.00042	0.000494	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—stomach cancer	0.00042	0.000493	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000419	0.000492	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PPP2R1A—stomach cancer	0.000418	0.00329	CbGpPWpGaD
Baclofen—Hyperhidrosis—Methotrexate—stomach cancer	0.000418	0.000491	CcSEcCtD
Baclofen—Discomfort—Epirubicin—stomach cancer	0.000417	0.00049	CcSEcCtD
Baclofen—Asthenia—Capecitabine—stomach cancer	0.000416	0.000489	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PRKAA1—stomach cancer	0.000416	0.00328	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AGTR2—stomach cancer	0.000415	0.00327	CbGpPWpGaD
Baclofen—Malaise—Doxorubicin—stomach cancer	0.000413	0.000486	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—WWOX—stomach cancer	0.000413	0.00325	CbGpPWpGaD
Baclofen—Dry mouth—Epirubicin—stomach cancer	0.000412	0.000485	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—stomach cancer	0.000412	0.000484	CcSEcCtD
Baclofen—Anorexia—Methotrexate—stomach cancer	0.000412	0.000484	CcSEcCtD
Baclofen—Syncope—Doxorubicin—stomach cancer	0.000411	0.000483	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—F2R—stomach cancer	0.000411	0.00323	CbGpPWpGaD
Baclofen—Pruritus—Capecitabine—stomach cancer	0.00041	0.000483	CcSEcCtD
Baclofen—Diarrhoea—Docetaxel—stomach cancer	0.00041	0.000482	CcSEcCtD
Baclofen—Confusional state—Epirubicin—stomach cancer	0.000408	0.000479	CcSEcCtD
Baclofen—Palpitations—Doxorubicin—stomach cancer	0.000405	0.000476	CcSEcCtD
Baclofen—Oedema—Epirubicin—stomach cancer	0.000404	0.000475	CcSEcCtD
Baclofen—Hypotension—Methotrexate—stomach cancer	0.000404	0.000474	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—stomach cancer	0.000403	0.000473	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RBP4—stomach cancer	0.000402	0.00316	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—stomach cancer	0.000402	0.00316	CbGpPWpGaD
Baclofen—Infection—Epirubicin—stomach cancer	0.000402	0.000472	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000401	0.00316	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—HTR1A—stomach cancer	0.0004	0.00315	CbGpPWpGaD
Baclofen—Shock—Epirubicin—stomach cancer	0.000398	0.000467	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—stomach cancer	0.000397	0.000467	CcSEcCtD
Baclofen—Diarrhoea—Capecitabine—stomach cancer	0.000397	0.000467	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—stomach cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Dizziness—Docetaxel—stomach cancer	0.000396	0.000466	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—stomach cancer	0.000396	0.000465	CcSEcCtD
Baclofen—Tachycardia—Epirubicin—stomach cancer	0.000395	0.000464	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000394	0.000463	CcSEcCtD
Baclofen—Skin disorder—Epirubicin—stomach cancer	0.000393	0.000462	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—stomach cancer	0.000391	0.000459	CcSEcCtD
Baclofen—Insomnia—Methotrexate—stomach cancer	0.000391	0.000459	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—stomach cancer	0.00039	0.000459	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—stomach cancer	0.00039	0.000459	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—stomach cancer	0.000389	0.000457	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—stomach cancer	0.000388	0.000456	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000387	0.000455	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—ANXA1—stomach cancer	0.000386	0.00304	CbGpPWpGaD
Baclofen—Discomfort—Doxorubicin—stomach cancer	0.000385	0.000453	CcSEcCtD
Baclofen—Anorexia—Epirubicin—stomach cancer	0.000385	0.000453	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—stomach cancer	0.000385	0.000453	CcSEcCtD
Baclofen—Somnolence—Methotrexate—stomach cancer	0.000384	0.000451	CcSEcCtD
Baclofen—Dizziness—Capecitabine—stomach cancer	0.000384	0.000451	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—WIF1—stomach cancer	0.000384	0.00302	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRH4—stomach cancer	0.000384	0.00302	CbGpPWpGaD
Baclofen—Dry mouth—Doxorubicin—stomach cancer	0.000382	0.000449	CcSEcCtD
Baclofen—Vomiting—Docetaxel—stomach cancer	0.000381	0.000448	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—stomach cancer	0.00038	0.000447	CcSEcCtD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—stomach cancer	0.00038	0.00299	CbGpPWpGaD
Baclofen—Rash—Docetaxel—stomach cancer	0.000378	0.000444	CcSEcCtD
Baclofen—Hypotension—Epirubicin—stomach cancer	0.000378	0.000444	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—stomach cancer	0.000378	0.000444	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—stomach cancer	0.000377	0.000443	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AGTR2—stomach cancer	0.000377	0.00297	CbGpPWpGaD
Baclofen—Decreased appetite—Methotrexate—stomach cancer	0.000375	0.000441	CcSEcCtD
Baclofen—Headache—Docetaxel—stomach cancer	0.000375	0.000441	CcSEcCtD
Baclofen—Oedema—Doxorubicin—stomach cancer	0.000374	0.00044	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—ADRB1—stomach cancer	0.000374	0.00294	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000373	0.000438	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—F2R—stomach cancer	0.000373	0.00294	CbGpPWpGaD
Baclofen—Fatigue—Methotrexate—stomach cancer	0.000372	0.000438	CcSEcCtD
Baclofen—Infection—Doxorubicin—stomach cancer	0.000372	0.000437	CcSEcCtD
Baclofen—Pain—Methotrexate—stomach cancer	0.000369	0.000434	CcSEcCtD
Baclofen—Vomiting—Capecitabine—stomach cancer	0.000369	0.000434	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000368	0.000433	CcSEcCtD
Baclofen—Shock—Doxorubicin—stomach cancer	0.000368	0.000433	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—stomach cancer	0.000367	0.000431	CcSEcCtD
Baclofen—Rash—Capecitabine—stomach cancer	0.000366	0.00043	CcSEcCtD
Baclofen—Insomnia—Epirubicin—stomach cancer	0.000366	0.00043	CcSEcCtD
Baclofen—Dermatitis—Capecitabine—stomach cancer	0.000365	0.00043	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—stomach cancer	0.000365	0.000429	CcSEcCtD
Baclofen—Headache—Capecitabine—stomach cancer	0.000363	0.000427	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—stomach cancer	0.000363	0.000427	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HTR1A—stomach cancer	0.000363	0.00286	CbGpPWpGaD
Baclofen—Paraesthesia—Epirubicin—stomach cancer	0.000363	0.000427	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—stomach cancer	0.000362	0.000425	CcSEcCtD
Baclofen—Dyspnoea—Epirubicin—stomach cancer	0.00036	0.000424	CcSEcCtD
Baclofen—Somnolence—Epirubicin—stomach cancer	0.000359	0.000422	CcSEcCtD
Baclofen—Anorexia—Doxorubicin—stomach cancer	0.000357	0.000419	CcSEcCtD
Baclofen—Nausea—Docetaxel—stomach cancer	0.000356	0.000418	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—stomach cancer	0.000356	0.000418	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—stomach cancer	0.000356	0.000418	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—MAPK1—stomach cancer	0.000356	0.0028	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKAB1—stomach cancer	0.000354	0.00279	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Methotrexate—stomach cancer	0.000353	0.000415	CcSEcCtD
Baclofen—Decreased appetite—Epirubicin—stomach cancer	0.000351	0.000413	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ANXA1—stomach cancer	0.000351	0.00276	CbGpPWpGaD
Baclofen—Hypotension—Doxorubicin—stomach cancer	0.000349	0.000411	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000349	0.00041	CcSEcCtD
Baclofen—Fatigue—Epirubicin—stomach cancer	0.000348	0.00041	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HSPB1—stomach cancer	0.000346	0.00272	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGTR2—stomach cancer	0.000346	0.00272	CbGpPWpGaD
Baclofen—Constipation—Epirubicin—stomach cancer	0.000346	0.000406	CcSEcCtD
Baclofen—Pain—Epirubicin—stomach cancer	0.000346	0.000406	CcSEcCtD
Baclofen—Nausea—Capecitabine—stomach cancer	0.000345	0.000405	CcSEcCtD
Baclofen—Urticaria—Methotrexate—stomach cancer	0.000343	0.000403	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—BMP2—stomach cancer	0.000342	0.00269	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RNF43—stomach cancer	0.000342	0.00269	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KISS1—stomach cancer	0.000342	0.00269	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—F2R—stomach cancer	0.000342	0.00269	CbGpPWpGaD
Baclofen—Body temperature increased—Methotrexate—stomach cancer	0.000341	0.000401	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—stomach cancer	0.000341	0.000401	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000341	0.000401	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ADRB1—stomach cancer	0.00034	0.00267	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—HRAS—stomach cancer	0.000339	0.00267	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—stomach cancer	0.000338	0.000398	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—AKR1C3—stomach cancer	0.000336	0.00265	CbGpPWpGaD
Baclofen—Paraesthesia—Doxorubicin—stomach cancer	0.000336	0.000395	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—stomach cancer	0.000333	0.000392	CcSEcCtD
Baclofen—Feeling abnormal—Epirubicin—stomach cancer	0.000333	0.000392	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HTR1A—stomach cancer	0.000333	0.00262	CbGpPWpGaD
Baclofen—Somnolence—Doxorubicin—stomach cancer	0.000332	0.000391	CcSEcCtD
Baclofen—Gastrointestinal pain—Epirubicin—stomach cancer	0.000331	0.000389	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—stomach cancer	0.000329	0.000387	CcSEcCtD
Baclofen—Decreased appetite—Doxorubicin—stomach cancer	0.000325	0.000382	CcSEcCtD
Baclofen—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000323	0.00038	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—stomach cancer	0.000322	0.000379	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PRKCB—stomach cancer	0.000322	0.00254	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ANXA1—stomach cancer	0.000321	0.00253	CbGpPWpGaD
Baclofen—Urticaria—Epirubicin—stomach cancer	0.000321	0.000377	CcSEcCtD
Baclofen—Pain—Doxorubicin—stomach cancer	0.00032	0.000376	CcSEcCtD
Baclofen—Constipation—Doxorubicin—stomach cancer	0.00032	0.000376	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—stomach cancer	0.00032	0.000376	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—stomach cancer	0.00032	0.000376	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ADRB1—stomach cancer	0.000311	0.00245	CbGpPWpGaD
Baclofen—Asthenia—Methotrexate—stomach cancer	0.00031	0.000364	CcSEcCtD
Baclofen—Feeling abnormal—Doxorubicin—stomach cancer	0.000308	0.000362	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000306	0.00036	CcSEcCtD
Baclofen—Pruritus—Methotrexate—stomach cancer	0.000306	0.000359	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FST—stomach cancer	0.000305	0.0024	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB2—stomach cancer	0.000303	0.00238	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HBEGF—stomach cancer	0.000298	0.00235	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RPS6—stomach cancer	0.000297	0.00234	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—stomach cancer	0.000297	0.000349	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—stomach cancer	0.000296	0.000348	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—stomach cancer	0.000296	0.000348	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—stomach cancer	0.000296	0.000347	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—GAST—stomach cancer	0.000294	0.00231	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RGS2—stomach cancer	0.000294	0.00231	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PRKCB—stomach cancer	0.000293	0.0023	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6ST—stomach cancer	0.000291	0.00229	CbGpPWpGaD
Baclofen—Asthenia—Epirubicin—stomach cancer	0.00029	0.000341	CcSEcCtD
Baclofen—Pruritus—Epirubicin—stomach cancer	0.000286	0.000336	CcSEcCtD
Baclofen—Dizziness—Methotrexate—stomach cancer	0.000286	0.000336	CcSEcCtD
Baclofen—GABBR1—Transmission across Chemical Synapses—HRAS—stomach cancer	0.000286	0.00225	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGG—stomach cancer	0.000279	0.00219	CbGpPWpGaD
Baclofen—Diarrhoea—Epirubicin—stomach cancer	0.000277	0.000325	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ADRB2—stomach cancer	0.000275	0.00217	CbGpPWpGaD
Baclofen—Vomiting—Methotrexate—stomach cancer	0.000275	0.000323	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HBEGF—stomach cancer	0.000273	0.00215	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—MAPK1—stomach cancer	0.000272	0.00215	CbGpPWpGaD
Baclofen—Rash—Methotrexate—stomach cancer	0.000272	0.00032	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—stomach cancer	0.000272	0.00032	CcSEcCtD
Baclofen—Headache—Methotrexate—stomach cancer	0.000271	0.000318	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PPP2R1A—stomach cancer	0.00027	0.00212	CbGpPWpGaD
Baclofen—Asthenia—Doxorubicin—stomach cancer	0.000268	0.000315	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PRKAA1—stomach cancer	0.000268	0.00211	CbGpPWpGaD
Baclofen—Dizziness—Epirubicin—stomach cancer	0.000267	0.000314	CcSEcCtD
Baclofen—Pruritus—Doxorubicin—stomach cancer	0.000265	0.000311	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—IL6R—stomach cancer	0.00026	0.00205	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RBP4—stomach cancer	0.000259	0.00204	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—stomach cancer	0.000259	0.00204	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—RHOA—stomach cancer	0.000259	0.00204	CbGpPWpGaD
Baclofen—Vomiting—Epirubicin—stomach cancer	0.000257	0.000302	CcSEcCtD
Baclofen—Nausea—Methotrexate—stomach cancer	0.000257	0.000302	CcSEcCtD
Baclofen—Diarrhoea—Doxorubicin—stomach cancer	0.000256	0.000301	CcSEcCtD
Baclofen—Rash—Epirubicin—stomach cancer	0.000255	0.0003	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—stomach cancer	0.000255	0.000299	CcSEcCtD
Baclofen—Headache—Epirubicin—stomach cancer	0.000253	0.000298	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ADRB2—stomach cancer	0.000252	0.00199	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—stomach cancer	0.000247	0.000291	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PPP2R1A—stomach cancer	0.000247	0.00195	CbGpPWpGaD
Baclofen—Nausea—Epirubicin—stomach cancer	0.00024	0.000282	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—stomach cancer	0.000238	0.00028	CcSEcCtD
Baclofen—Rash—Doxorubicin—stomach cancer	0.000236	0.000277	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—stomach cancer	0.000236	0.000277	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—RHOA—stomach cancer	0.000235	0.00185	CbGpPWpGaD
Baclofen—Headache—Doxorubicin—stomach cancer	0.000234	0.000275	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SMAD4—stomach cancer	0.000229	0.00181	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—stomach cancer	0.000227	0.00179	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HSPB1—stomach cancer	0.000223	0.00175	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGTR2—stomach cancer	0.000223	0.00175	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—stomach cancer	0.000222	0.000261	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BMP2—stomach cancer	0.00022	0.00173	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—F2R—stomach cancer	0.00022	0.00173	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HRAS—stomach cancer	0.000219	0.00172	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FYN—stomach cancer	0.000218	0.00172	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKR1C3—stomach cancer	0.000217	0.00171	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR1A—stomach cancer	0.000214	0.00169	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000213	0.00168	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCB—stomach cancer	0.000208	0.00163	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ANXA1—stomach cancer	0.000207	0.00163	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—stomach cancer	0.000206	0.00162	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGFR2—stomach cancer	0.000205	0.00161	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB1—stomach cancer	0.000201	0.00158	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RPS6—stomach cancer	0.000192	0.00151	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCB—stomach cancer	0.000189	0.00148	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6ST—stomach cancer	0.000188	0.00148	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IRS2—stomach cancer	0.000187	0.00147	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CAV1—stomach cancer	0.000182	0.00143	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APOA1—stomach cancer	0.000181	0.00143	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000181	0.00142	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HBEGF—stomach cancer	0.000176	0.00139	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCB—stomach cancer	0.000173	0.00136	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6ST—stomach cancer	0.000172	0.00136	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6R—stomach cancer	0.000168	0.00132	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—RHOA—stomach cancer	0.000167	0.00131	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—stomach cancer	0.000165	0.0013	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB2—stomach cancer	0.000163	0.00128	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PPP2R1A—stomach cancer	0.000159	0.00125	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—stomach cancer	0.000158	0.00125	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6R—stomach cancer	0.000154	0.00121	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—RHOA—stomach cancer	0.000151	0.00119	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK1—stomach cancer	0.000151	0.00119	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—stomach cancer	0.000151	0.00119	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SMAD4—stomach cancer	0.000148	0.00116	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—stomach cancer	0.000146	0.00115	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—stomach cancer	0.000144	0.00113	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—stomach cancer	0.000144	0.00113	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—stomach cancer	0.000142	0.00112	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FYN—stomach cancer	0.00014	0.00111	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RHOA—stomach cancer	0.000139	0.00109	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOS3—stomach cancer	0.000137	0.00108	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000137	0.00108	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—stomach cancer	0.000133	0.00105	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGFR2—stomach cancer	0.000132	0.00104	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—stomach cancer	0.000131	0.00103	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB2—stomach cancer	0.000128	0.00101	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—stomach cancer	0.000122	0.000959	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HRAS—stomach cancer	0.000121	0.000953	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IRS2—stomach cancer	0.000121	0.00095	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—stomach cancer	0.000119	0.000936	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CAV1—stomach cancer	0.000117	0.000921	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APOA1—stomach cancer	0.000117	0.000919	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—stomach cancer	0.000116	0.000912	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCND1—stomach cancer	0.000113	0.000893	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—stomach cancer	0.000113	0.000891	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCB—stomach cancer	0.000111	0.000877	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6ST—stomach cancer	0.000111	0.000873	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—stomach cancer	0.00011	0.000867	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—stomach cancer	0.00011	0.000864	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—stomach cancer	0.000108	0.000854	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK8—stomach cancer	0.000107	0.000843	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—stomach cancer	0.000107	0.000839	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—stomach cancer	0.000102	0.000804	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6R—stomach cancer	9.9e-05	0.000779	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—stomach cancer	9.89e-05	0.000779	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—stomach cancer	9.8e-05	0.000771	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAPK1—stomach cancer	9.71e-05	0.000765	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—stomach cancer	9.71e-05	0.000765	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—stomach cancer	9.36e-05	0.000737	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—stomach cancer	9.28e-05	0.000731	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—stomach cancer	9.27e-05	0.00073	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—KRAS—stomach cancer	9.17e-05	0.000722	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MYC—stomach cancer	9.1e-05	0.000717	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RHOA—stomach cancer	8.94e-05	0.000704	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK1—stomach cancer	8.9e-05	0.000701	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—stomach cancer	8.9e-05	0.000701	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOS3—stomach cancer	8.85e-05	0.000697	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—stomach cancer	8.43e-05	0.000664	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—stomach cancer	8.41e-05	0.000662	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—stomach cancer	8.28e-05	0.000652	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—stomach cancer	7.85e-05	0.000618	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRAS—stomach cancer	7.8e-05	0.000614	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—stomach cancer	7.73e-05	0.000608	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—stomach cancer	7.66e-05	0.000603	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—stomach cancer	7.47e-05	0.000588	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—stomach cancer	7.46e-05	0.000588	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—stomach cancer	7.31e-05	0.000576	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUN—stomach cancer	7.3e-05	0.000574	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRAS—stomach cancer	7.15e-05	0.000563	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—stomach cancer	7.1e-05	0.000559	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—stomach cancer	7.07e-05	0.000557	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK8—stomach cancer	6.9e-05	0.000544	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—stomach cancer	6.84e-05	0.000539	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—stomach cancer	6.37e-05	0.000502	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—stomach cancer	6.31e-05	0.000497	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—stomach cancer	6.03e-05	0.000475	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—stomach cancer	5.87e-05	0.000462	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK1—stomach cancer	5.74e-05	0.000452	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—stomach cancer	5.74e-05	0.000452	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—stomach cancer	5.42e-05	0.000427	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—stomach cancer	4.98e-05	0.000392	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—stomach cancer	4.82e-05	0.000379	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—stomach cancer	4.61e-05	0.000363	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—stomach cancer	4.41e-05	0.000347	CbGpPWpGaD
